Seeking a better shield: new chemo tested to stop testicular Cancer's return
NCT ID NCT02341989
Summary
This study is for men with early-stage testicular cancer who have a higher risk of the cancer coming back. It compares two different single-dose chemotherapy treatments given after surgery to see which one is better at preventing a relapse. The goal is to find the treatment with the lowest chance of the cancer returning while also comparing side effects and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEMINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institutt for kreftforskning og molekylær medisin, St Olavs Hospital
Trondheim, Norway
-
St. Olavs University hospital HF
Trondheim, Norway
Conditions
Explore the condition pages connected to this study.